XENCOR INC. DL-,01 |
USA |
Gesundheit |
US98401F1057 / A1W96L |
XE9 (Frankfurt) / XNCR (NASDAQ) |
FRA:XE9, ETR:XE9, XE9:GR, NASDAQ:XNCR |
- |
- |
Xencor Inc. is a biopharmaceutical company dedicat..
>Volltext.. |
464.57 Mio. EUR |
268.68 Mio. EUR |
126.09 Mio. EUR |
-114.43 Mio. EUR |
-146.82 Mio. EUR |
-2.07 EUR |
182.75 Mio. EUR |
38.14 Mio. EUR |
-112.05 Mio. EUR |
4.62 |
-10.95% |
18.64% |
- |
- |
- |
- |
XENCOR |
21.08.25 |
|